New vaccines for a safer world

In a world characterized by increasing population density, human mobility, and ecological change, emerging infectious diseases pose a real and growing threat to global health security. Epidemic diseases affect us all. They do not respect borders. Vaccines are one of our most powerful tools in the fight to outsmart epidemics.

The Coalition for Epidemic Preparedness Innovation’s (CEPI’s) mission is to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks. The rapid global spread and unique epidemiological characteristics of the novel coronavirus are deeply concerning. CEPI has moved with great urgency and in coordination with WHO, who is leading the development of a coordinated international response. So far, we have initiated 8 partnerships to improve our understanding and to develop vaccines against the novel coronavirus. The programmes will leverage rapid response platforms already supported by CEPI as well as new partnerships. The aim is to advance COVID-19 vaccine candidates into clinical testing as quickly as possible.